First and second line drug resistance among treatment naive pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme [RNTCP] in New Delhi

Vithal Prasad, Myneedu; Ritu, Singhal; Khalid Umer, Khayyam; Prem Prakash, Sharma; Manpreet, Bhalla; Digamber, Behera; Rohit, Sarin.
Journal of Epidemiology and Global Health. 2015; 5 (4): 365-373
en Inglés | IMEMR | ID: emr-173831

Documentos relacionados

  1. Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa.
  2. The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
  3. Nano vs Resistant Tuberculosis: Taking the Lung Route.
  4. Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China.
  5. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study.
  6. Has the Time Come for Systematic Therapeutic Drug Monitoring of First-Line and WHO Group A Antituberculosis Drugs?
  7. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
  8. Clinical and epidemiological features of tuberculosis isolated from critically ill patients.
  9. A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
  10. Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates.